42 results
8-K
EX-99.1
COCP
Cocrystal Pharma Inc
11 May 22
Cocrystal Pharma Reports First Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs and Milestones
8:30am
in the current challenging economic environment, given our clean capital structure and a cash balance we believe is sufficient to fund planned operations
8-K
EX-1.1
COCP
Cocrystal Pharma Inc
5 May 21
Entry into a Material Definitive Agreement
5:02pm
to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata … substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise relating to the manufacture, processing, distribution, use
8-K
EX-1.1
smita3pdu p13ojcr
27 Aug 20
Entry into a Material Definitive Agreement
5:25pm
8-K
EX-1.1
du635lmbp4wdq0y6j
2 Jul 20
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.1
ucprvvf
13 Mar 20
Cocrystal Pharma Announces Closing of $6.8 Million Registered Direct Offering Priced At-the-Market
4:44pm
8-K
EX-10.1
75wk g2fujvifd
4 Mar 20
Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market
5:09pm
8-K
EX-10.1
f5mb 4u01
31 Jan 20
Entry into a Material Definitive Agreement
8:01am
8-K
EX-1.1
43l4kk
31 Oct 19
Entry into a Material Definitive Agreement
9:29am
8-K
EX-1.1
ad8lrqoghp5oyv
30 Oct 19
Entry into a Material Definitive Agreement
4:38pm
8-K
EX-10.1
oivl hk07s1xfhg4
11 Mar 19
Cocrystal Pharma Announces Closing of Private Placement
8:35am